| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.097 | 0.5 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.5 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.5 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |